David Gray

SchoolVc-academic Affairs
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Supplementary strategies identified additional eligible studies in qualitative systematic reviews. J Clin Epidemiol. 2023 07; 159:85-91. Frandsen TF, Eriksen MB. PMID: 37201687.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease. Biomolecules. 2023 05 12; 13(5). Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, Duvvuri S, Gray DL, Huang X, Mailman RB. PMID: 37238699; PMCID: PMC10216182.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Porcine reproductive and respiratory syndrome virus degrades DDX10 via SQSTM1/p62-dependent selective autophagy to antagonize its antiviral activity. Autophagy. 2023 08; 19(8):2257-2274. Li J, Zhou Y, Zhao W, Liu J, Ullah R, Fang P, Fang L, Xiao S. PMID: 36779599; PMCID: PMC10351467.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    4. [Determination of organophosphate diesters in facility vegetable soils using ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry]. Se Pu. 2023 Jan; 41(1):58-65. Liu M, Wang M, Zhao A, Zhu L, Wang C, Wei C, Liu W, Xu J. PMID: 36633077.
      View in: PubMed   Mentions:    Fields:    
    5. Illness Phase as a Key Assessment and Intervention Window for Psychosis. Biol Psychiatry Glob Open Sci. 2023 Jul; 3(3):340-350. Kohler CG, Wolf DH, Abi-Dargham A, Anticevic A, Cho YT, Fonteneau C, Gil R, Girgis RR, Gray DL, Grinband J, Javitch JA, Kantrowitz JT, Krystal JH, Lieberman JA, Murray JD, Ranganathan M, Santamauro N, Van Snellenberg JX, Tamayo Z, TRANSCENDS Group, Gur RC, Gur RE, Calkins ME. PMID: 37519466; PMCID: PMC10382701.
      View in: PubMed   Mentions:
    6. The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey. Front Aging Neurosci. 2021; 13:757850. Moore TL, Young DA, Killiany RJ, Fonseca KR, Volfson D, Gray DL, Balice-Gordon R, Kozak R. PMID: 34899271; PMCID: PMC8662559.
      View in: PubMed   Mentions:
    7. Parkinson disease among patients treated for benign prostatic hyperplasia with α1 adrenergic receptor antagonists. J Clin Invest. 2021 06 01; 131(11). Sasane R, Bartels A, Field M, Sierra MI, Duvvuri S, Gray DL, Pin SS, Renger JJ, Stone DJ. PMID: 33822767; PMCID: PMC8159680.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    8. Injury, Illness, and Mental Health Risks in United States Domestic Mariners. J Occup Environ Med. 2020 10; 62(10):839-841. Lefkowitz RY, Null DB, Slade MD, Redlich CA. PMID: 32769797.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Front Pharmacol. 2020; 11:1005. Kozak R, Kiss T, Dlugolenski K, Johnson DE, Gorczyca RR, Kuszpit K, Harvey BD, Stolyar P, Sukoff Rizzo SJ, Hoffmann WE, Volfson D, Hajós M, Davoren JE, Abbott AL, Williams GV, Castner SA, Gray DL. PMID: 32733245; PMCID: PMC7358525.
      View in: PubMed   Mentions: 12  
    10. A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity. Int J Neuropsychopharmacol. 2020 05 27; 23(5):287-299. Balice-Gordon R, Honey GD, Chatham C, Arce E, Duvvuri S, Naylor MG, Liu W, Xie Z, DeMartinis N, Harel BT, Braley GH, Kozak R, Park L, Gray DL. PMID: 32055822; PMCID: PMC7251631.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    11. Imaging examination, diagnosis, and control and prevention of nosocomial infection for coronavirus disease 2019: Expert consensus of Hunan radiologist. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Mar 28; 45(3):221-228. Liu J, Wang W. PMID: 32386011.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    12. D1 Agonist Improved Movement of Parkinsonian Nonhuman Primates with Limited Dyskinesia Side Effects. ACS Chem Neurosci. 2020 02 19; 11(4):560-566. Young D, Popiolek M, Trapa P, Fonseca KR, Brevard J, Gray DL, Kozak R. PMID: 31971364.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    13. The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study. J Parkinsons Dis. 2020; 10(4):1515-1527. Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, Mahoney SE, Gray DL, Mailman RB. PMID: 32986682; PMCID: PMC8640973.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    14. Dopaminergic D1 Receptor Stimulation Affects Effort and Risk Preferences. Biol Psychiatry. 2020 04 01; 87(7):678-685. Soutschek A, Gvozdanovic G, Kozak R, Duvvuri S, de Martinis N, Harel B, Gray DL, Fehr E, Jetter A, Tobler PN. PMID: 31668477.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    15. The Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument. Mov Disord Clin Pract. 2019 Nov; 6(8):678-686. Deal LS, Flood E, Myers DE, Devine J, Gray DL. PMID: 31745478; PMCID: PMC6856450.
      View in: PubMed   Mentions: 5  
    16. A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia. J Psychopharmacol. 2019 10; 33(10):1237-1247. Arce E, Balice-Gordon R, Duvvuri S, Naylor M, Xie Z, Harel B, Kozak R, Gray DL, DeMartinis N. PMID: 31264510.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    17. A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex. Neuropharmacology. 2019 05 15; 150:46-58. Wang M, Datta D, Enwright J, Galvin V, Yang ST, Paspalas C, Kozak R, Gray DL, Lewis DA, Arnsten AFT. PMID: 30858103; PMCID: PMC6475613.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    18. Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration. Neurodegener Dis. 2018; 18(5-6):262-269. Papapetropoulos S, Liu W, Duvvuri S, Thayer K, Gray DL. PMID: 30453303.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    19. Phase 1 Parkinson's Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated. Neurol Ther. 2018 Dec; 7(2):307-319. Sohur US, Gray DL, Duvvuri S, Zhang Y, Thayer K, Feng G. PMID: 30361858; PMCID: PMC6283789.
      View in: PubMed   Mentions: 18  
    20. Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nat Commun. 2018 02 14; 9(1):674. Gray DL, Allen JA, Mente S, O'Connor RE, DeMarco GJ, Efremov I, Tierney P, Volfson D, Davoren J, Guilmette E, Salafia M, Kozak R, Ehlers MD. PMID: 29445200; PMCID: PMC5813016.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    21. Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network. Bioorg Med Chem. 2016 08 15; 24(16):3513-20. Sciabola S, Goetz GH, Bai G, Rogers BN, Gray DL, Duplantier A, Fonseca KR, Vanase-Frawley MA, Kablaoui NM. PMID: 27297999.
      View in: PubMed   Mentions: 8     Fields:    Translation:Cells
    22. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia. Biol Psychiatry. 2017 01 01; 81(1):67-77. Arnsten AF, Girgis RR, Gray DL, Mailman RB. PMID: 26946382; PMCID: PMC4949134.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimals
    23. Measurement of atropisomer racemization kinetics using segmented flow technology. ACS Med Chem Lett. 2012 May 10; 3(5):433-5. Davoren JE, Bundesmann MW, Yan QT, Collantes EM, Mente S, Nason DM, Gray DL. PMID: 24900489; PMCID: PMC4025797.
      View in: PubMed   Mentions:
    24. Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists. Bioorg Med Chem Lett. 2011 Jan 15; 21(2):865-8. Pettersson M, Campbell BM, Dounay AB, Gray DL, Xie L, O'Donnell CJ, Stratman NC, Zoski K, Drummond E, Bora G, Probert A, Whisman T. PMID: 21185183.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    25. Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists. Bioorg Med Chem Lett. 2010 Feb 01; 20(3):1114-7. Dounay AB, Barta NS, Campbell BM, Coleman C, Collantes EM, Denny L, Dutta S, Gray DL, Hou D, Iyer R, Maiti SN, Ortwine DF, Probert A, Stratman NC, Subedi R, Whisman T, Xu W, Zoski K. PMID: 20031410.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    26. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists. Bioorg Med Chem Lett. 2009 Dec 01; 19(23):6604-7. Gray DL, Xu W, Campbell BM, Dounay AB, Barta N, Boroski S, Denny L, Evans L, Stratman N, Probert A. PMID: 19854053.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    27. Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists. Bioorg Med Chem Lett. 2009 Feb 15; 19(4):1159-63. Dounay AB, Barta NS, Bikker JA, Borosky SA, Campbell BM, Crawford T, Denny L, Evans LM, Gray DL, Lee P, Lenoir EA, Xu W. PMID: 19147349.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    28. Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors. Bioorg Med Chem Lett. 2008 Oct 15; 18(20):5550-3. Xu W, Gray DL, Glase SA, Barta NS. PMID: 18805691.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity. Bioorg Med Chem Lett. 2008 Aug 01; 18(15):4355-9. Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA. PMID: 18621528.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    30. Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol. 2008 Jun 15; 180(12):8241-9. Chauhan VS, Sterka DG, Gray DL, Bost KL, Marriott I. PMID: 18523290; PMCID: PMC2507752.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    31. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone. 2005 Oct; 37(4):504-12. Marriott I, Gray DL, Rati DM, Fowler VG, Stryjewski ME, Levin LS, Hudson MC, Bost KL. PMID: 16027056.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    32. Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Am J Pathol. 2004 Apr; 164(4):1399-406. Marriott I, Gray DL, Tranguch SL, Fowler VG, Stryjewski M, Scott Levin L, Hudson MC, Bost KL. PMID: 15039227; PMCID: PMC1615361.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    33. Total synthesis of hybocarpone and analogues thereof. A facile dimerization of naphthazarins to pentacyclic systems. J Am Chem Soc. 2004 Jan 21; 126(2):607-12. Nicolaou KC, Gray DL. PMID: 14719960.
      View in: PubMed   Mentions: 12     Fields:    Translation:Cells
    34. Total synthesis of hamigerans and analogues thereof. Photochemical generation and Diels-Alder trapping of hydroxy-o-quinodimethanes. J Am Chem Soc. 2004 Jan 21; 126(2):613-27. Nicolaou KC, Gray DL, Tae J. PMID: 14719961.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    35. Oxidation of silyl enol ethers by using IBX and IBX.N-oxide complexes: a mild and selective reaction for the synthesis of enones. Angew Chem Int Ed Engl. 2002 Mar 15; 41(6):996-1000. Nicolaou KC, Gray DL, Montagnon T, Harrison ST. PMID: 12491292.
      View in: PubMed   Mentions: 32     Fields:    
    David's Networks
    Concepts (184)
    Derived automatically from this person's publications.
    Co-Authors (376)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department